Comparing the current results to its competitors, Nuwellis Inc reported Revenue increase in the 2 quarter 2026 by 14.14 % year on year. The sales growth was above Nuwellis Inc 's competitors' average revenue growth of 10.13 %, achieved in the same quarter.
Nuwellis Inc 's Comment on Competition and Industry Peers
The Aquadex System competes with medical device companies, healthcare divisions, pharmaceutical companies, and gene- and cell-based therapies. In the United States, diuretics are the primary direct competitors for treating fluid overload in heart failure or critical care patients. Indirect competitors include Baxter’s Prismaflex, a filter-based device approved for continuous renal replacement therapy in patients with acute renal failure and/or fluid overload, though it has notable limitations. In pediatric care, the Carpediem system, distributed by Medtronic, is used for acute kidney injury or fluid overload requiring hemodialysis or hemofiltration therapy. Baxter’s HF20 Set is also referenced as a competitor.
March 7, 2024
Heart failure continues to be a major global health burden, affecting millions of individuals and causing substantial morbidity and mortality. The management of heart failure patients has relied heavily on the use of intravenous loop diuretics to alleviate fluid overload. However, recent studies have shown promising results with ultrafiltration therapy, using the Aquadex System, in improving outcomes and reducing heart failure events and hospitalizations. In addition, the application of artificial intelligence (AI) and machine learning (ML) in developing predictive models has unveiled the potential for improved risk stratification and personalized management strategies for heart failure patients.Ultrafiltrat...
Anika Therapeutics Inc is a medical technology company that focuses on developing and commercializing therapeutic products to treat tissue-related disorders. Their business model revolves around conducting extensive research and development to create innovative therapies, partnering with healthcare professionals and distributors to bring their products to market, and generating revenue through the sale of these products worldwide. They also collaborate with other companies and academic institutions to enhance their product portfolio and expand their reach in the healthcare industry.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Monogram Orthopaedics Inc. operates on a specialized business model focused on developing and manufacturing innovative orthopedic medical devices. With a strong emphasis on research and development, they design cutting-edge solutions to address various musculoskeletal conditions. The company collaborates with healthcare professionals to test and refine their products, ensuring their efficacy and safety for patients.
Orthofix Medical Inc is a company that focuses on developing and selling medical devices and orthopedic solutions to healthcare providers and patients.
Avita Medical Inc is a medical technology company that specializes in regenerative medicine. Their business model focuses on developing and commercializing innovative products for the treatment of burns, chronic wounds, and other skin-related conditions.
Sources:
Nuwellis Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nuwellis Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
